Sensors from consumer-grade devices like iPhones, Apple Watches, iPads and Beddit sleep monitors capture enough data to spot mild cognitive impairment or Alzheimer’s disease dementia, according to a new feasibility study conducted jointly by Apple, Eli Lilly and Company and Evidation Health researchers that was presented today at a research conference held in Anchorage, Alaska.
“Over the past few...
This morning Altoida, a digital platform that uses artificial intelligence and machine learning to help predict Alzheimer’s disease, closed a $6.3 million Series A funding round. M Ventures led the round with participation from Grey Sky Venture Partners, VI Partners AGG, Alpana Ventures and FYRFLY Ventures.
WHAT THEY DO
Altoida makes a digital platform that employs AI, ML and augmented reality...
Optina Diagnostics, a Montreal-based company that uses spectral retinal imaging and artificial intelligence to scan for early Alzheimer’s disease, announced today that it has raised $4 million in seed funding. Zoic Capital led the round with participation from Desjardins Capital, DigitalDx Ventures, Pallasite Ventures, Barney Pell, Barney Pell's AngelList Syndicate, Advisors.fund and Hike...
Dthera Sciences, a San Diego-based developer of clinical and consumer digital therapeutics for individuals with neurodegenerative conditions, announced today that its development stage intervention, DTHR-ALZ, has been granted Breakthrough Device designation by the FDA.
As laid out in the 21st Century Cures Act, the Breakthrough Devices Program looks to streamline new medical technologies that...
Dementia-focused tech company Smart Brain Aging has announced the launch its virtual offering for the aging population.
Called Brain U Online, the service provides consumers with cognitive tasks that when paired with exercise have, according to the company, been proven to delay the progression of dementia and limit its negative impact.
“We developed Smart Brain Aging with one purpose: to help...
Boston-based Akili Interactive Labs and Pfizer have released data from a collaborative study showing the use of Akili’s digital, cognitive measurement platform can detect biomarkers of Alzheimer’s disease.
The study, which began in 2014, used Akili’s screening technology called AD Screen. The program targets the brain's interference processing system and then uses an algorithm to deploy a...
